Current evaluation of the cytokine status of children with atopic dermatitis
Abstract
In recent years, cytokines have played the most important role in the regulation of immunopathological mechanisms, allergic reactions in particular. The objective of the study was to determine the presence, frequency, and levels of cytokines in children with atopic dermatitis. Ninety patients with atopic dermatitis (a study group) and 11 children without signs of this condition (a comparison group) were examined. The levels of the interleukins IL-4, IL-5, IL-13, IL-17, IL-17F, IL-22, and TGF-β1 and the chemokines eotaxin and eotaxin-2 were determined in a single serum specimen by enzyme immunoassay. The cytokine status of children with atopic dermatitis was not established to fundamentally differ from that of the comparison group. However, the frequency and mean concentrations of interleukins and chemokines were different. The specific feature of a cytokine profile in children with atopic dermatitis lies in a marked imbalance in the levels of all the studied cytokines. The significant elevation of IL-4, IL-5, TGF-β1 , and IL-22 levels in children with atopic dermatitis suggest that consideration of the pathogenesis of this disease only in terms of the predominance of TH2 lymphocyte activation is more than sketchy.
About the Authors
T. V. Vinogradova
Research Clinical Institute of Pediatrics, Moscow
Russian Federation
Russian Federation
A. A. Chuslyaeva
Research Clinical Institute of Pediatrics, Moscow
Russian Federation
Russian Federation
E. E. Varlamov
Research Clinical Institute of Pediatrics, Moscow
Russian Federation
Russian Federation
E. A. Ruzhitskaya
Research Clinical Institute of Pediatrics, Moscow
Russian Federation
Russian Federation
V. S. Sukhorukov
Research Clinical Institute of Pediatrics, Moscow
Russian Federation
Russian Federation
A. N. Pampura
Research Clinical Institute of Pediatrics, Moscow
Russian Federation
Russian Federation
References
1. Garra A., Vieira P. Regulatory T-cells and mechanisms of immune system control. Nature Med 2004; 10: 801—805.
2. Симбирцев А.С. Цитокины в иммунопатогенезе и лечении аллергии. Рос аллергол журн 2007; 1: 5—19. (Simbirtsev A.S. Cytokines in allergy imunopatho-genesis and therapy. Ros Allergol Zhurn 2007; 1: 5—19.)
3. Foley S., Hamid Q. Inflammatory patterns in allergis rhinitis. Clin Exp Allergy Rev 2006; 11: 91—99.
4. Robinson D. Th2 cytokines in allergic disease. Brit Med Bull 2000; 56: 956—968.
5. Mattes J., Yang M., Siqueira A. et al. Il-13 induces airways hyperreactivity independently of IL-4Ra chain in the allergic lung. J Immunol 2001; 167: 1683—1692.
6. Rich R.R., Flesher T.A., Shearer W.T. et al. Clinical Immunology. Principles and Practice. Elsevier Limited, 2008; 1558.
7. Brandt E.B., Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol 2011; 2: 3: 110.
8. Cho S., Stanciu L., Holgate S., Johnston S. Increased interleukin-4, -5 and interferon-g in airway CD4+ and CD8+ T cell in atopic asthma. Am J Res Crit Care Med 2005; 171: 224—230.
9. Foster E., Simpson E., Fredrikson L. Eosinophils Increase Neuron Branching in Human and Murine Skin and In Vitro. Plos ONE 2011; 6: 22029.
10. Matsuura H., Ishigura A., Hiroyuki A. et al. Elevation of plasma eotaxin levels in children with food allergy. Jpn J Clin Immunol 2009; 32: 3: 180—185.
11. Owczarec W., Palpinska M., Targowski T. et al. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis. Cytokine 2010; 50: 181—185.
12. Louten J., Boniface K., de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 5: 1004—1011.
13. Commins S., Borish L., Steinke J. Immunologic messenger molecules: Cytokines, interferons and chemokines. J Allergy Clin Immunol 2010; 125: 2: 53—72.
14. Koga C., Kabashima K., Shiraishi N et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128: 2625—2630.
15. Nograles K.E., Zaba L.C., Guttman-Yassky E. et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyteresponce pathways. Br J Dermatol 2008; 159: 1092—1102.
16. Hayashida S., Uchi H., Moroi Y., Furue M. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. J Dermatol Sci 2011; 61: 3: 180—186.
17. Nograles K.E., Zaba L.C., Shemer A. et al. IL-22 — producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123: 1244—1252.
18. Duhen T., Geiger R., Jarrossay D. et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10, 857—863.
19. Wolk K., Witte E., Witte K. et al. Biology of interleukin 22. Semin Immunopathol 2010; 32: 17—31.
20. Li A.G., Wang D., Feng X.H., Wang X.J. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasislike skin disorder. EMBO J 2004; 23: 1770—1781.
21. Варламов Е.Е., Виноградова Т.В., Чусляева А.А., Пампура А.Н. Особенности цитокинового профиля у детей раннего возраста с множественной непереносимостью пищевых белков. Рос аллергол журн 2012; 5: 76—80. (Varlamov E.E., Vinogradova T.V., Chuslyaeva A.A., Pampura A.N. Features of the cytokine profile in infants with multiple food protein intolerance. Ros Allergol Zhurn 2012; 5: 76—80.)
22. Chen W., Jin W., Hardegen N. et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875—1886.
23. Варламов Е.Е., Виноградова Т.В., Чусляева А.А. и др. Биомаркеры аллергического воспаления и тяжесть атопического дерматита у детей. Рос аллергол журн 2012; 5, 31—35. (Varlamov E.E., Vinogradova T.V., Chuslyaeva A.A. et al. Biomarkers allergic inflammation and severity of atopic dermatitis at children. Ros Allergol Zhurn 2012; 5: 31—35.)
24. Jutel M., Akdis M., Budak F. et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205—1214.
25. Souwer Y., Szegedi K., Kapsenderg M. et al. IL-17 and IL-22 in atopic allergic disease. Current Opinion Immunol 2010; 22: 821—826.
26. Guttman-Yassky E., Nograles K., Krueger J. Contrasting pathogenesis of atopic dermatitis and psoriasis — Part II: Immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011; 127: 1420—1432. Виноградова Т.В. и соавт. Современная оценка цитокинового статуса детей при атопическом дерматите
27. Чусляева А.А., Виноградова Т.В., Сухоруков В.С., Пампу- ра А.Н. Уровень IL-17 и IL-22 в сыворотке крови у детей с атопическим дерматитом. Рос вестн перинатол и педиатр 2012; 5: 99—102. (Chuslyaeva A.A., Vinogradova T.V., Sukhorukov V.S., Pampura A.N. Serum IL-17 and IL-22 levels in children with atopic dermatitis. Ros Vestn Perinatol I Pediatr 2012; 5: 99—102.)
Review
For citations:
Vinogradova T.V., Chuslyaeva A.A., Varlamov E.E., Ruzhitskaya E.A., Sukhorukov V.S., Pampura A.N. Current evaluation of the cytokine status of children with atopic dermatitis. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(1):76-81. (In Russ.)
Views:
772
Email this article 